Stay updated on Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial

Sign up to get notified when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 was added to the study record history, while the previous revision v3.5.3 was removed from the visible list, reflecting an update to the record's version history.
    Difference
    0.1%
    Check dated 2026-05-14T22:27:14.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page’s footer/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting an internal release or interface revision.
    Difference
    0.1%
    Check dated 2026-04-23T22:08:20.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added to the history and the previous v3.5.0 entry was removed.
    Difference
    0.1%
    Check dated 2026-04-16T18:36:36.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T22:18:52.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    A new history entry Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the study record history.
    Difference
    0.1%
    Check dated 2026-03-11T17:57:07.000Z thumbnail image
  9. Check
    108 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed a general funding/status notice; these are minor maintenance updates to the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T02:17:01.000Z thumbnail image

Stay in the know with updates to Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.